FORM OF COMMON STOCK PURCHASE WARRANT HOTH THERAPEUTICS, INC.Hoth Therapeutics, Inc. • June 21st, 2018 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the seven-year anniversary of the Issue Date of the Warrant (the “Termination Date”) but not thereafter, to subscribe for and purchase from Hoth Therapeutics, Inc., a Nevada corporation (the “Company”), up to ____________ shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
UNIT PURCHASE AGREEMENT BY AND AMONG HOTH THERAPEUTICS, INC. AND THE PURCHASERS PARTY HERETOUnit Purchase Agreement • June 21st, 2018 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS UNIT PURCHASE AGREEMENT (the “Agreement”) is entered into as of the date set forth on the signature page hereto by and among Hoth Therapeutics, Inc., a Nevada corporation (the “Company”), and the purchasers identified on Exhibit A on the date hereof (which purchasers are hereinafter collectively referred to as the “Purchasers” and each individually as, a “Purchaser”).
Sublicense AgreementSublicense Agreement • June 21st, 2018 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS EXCLUSIVE SUBLICENSE AGREEMENT (the “Agreement”) is made as of May 26, 2017 (the “Effective Date”) by and between Chelexa BioSciences, Inc., with an address at 275 Grove Street, Suite 2-400, Auburndale, MA 02466 (“Chelexa”) and Hoth Therapeutics, Inc. with an address at 6 Horizon Road, Suite 1903, Fort Lee, New Jersey 07024 (‘·Hoth” ).
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • June 21st, 2018 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • Ohio
This Exclusive License Agreement (the “Agreement) is effective (the “Effective Date”) on the date the last of the Parties executes this Agreement, and is by and between the University of Cincinnati, a state institution of higher education organized under Section 3361 of the Ohio Revised Code, having an address at 51 Goodman Dr., Suite 240, Cincinnati, OH 45221-0829, (“UC”) and Hoth Therapeutics, Inc. (the “Licensee”), a company with offices at One Rockefeller Plaza, Suite 1039, New York, NY 10020 (the “Company”).
